compounds against recombinant sars cov 2 plpro (ACROBiosystems)
ACROBiosystems is a verified supplier 
95
Structured Review
ACROBiosystems
compounds against recombinant sars cov 2 plpro
Compounds Against Recombinant Sars Cov 2 Plpro, supplied by ACROBiosystems, used in various techniques. Bioz Stars score: 95/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/compounds+against+recombinant+sars+cov+2+plpro/SARS-CoV-2+(COVID-19)+Papain-like+Protease+Protein%2C+His+Tag/pm39816788-714-6-11
Average 95 stars, based on 3 article reviews
Compounds Against Recombinant Sars Cov 2 Plpro, supplied by ACROBiosystems, used in various techniques. Bioz Stars score: 95/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/compounds+against+recombinant+sars+cov+2+plpro/SARS-CoV-2+(COVID-19)+Papain-like+Protease+Protein%2C+His+Tag/pm39816788-714-6-11
Average 95 stars, based on 3 article reviews
compounds against recombinant sars cov 2 plpro - by Bioz Stars,
2026-09
95/100 stars
Images
Related Articles
Activity Assay:Article Title: Pyrazinyl-Substituted Aminoazoles as Covalent Inhibitors of Thrombin: Synthesis, Structure, and Anticoagulant Properties. Article Snippet: This study presents a novel series of N-acylated 1,2,4-triazol-5-amines and 1H-pyrazol-5-amines, featuring a pyrazin-2-yl moiety, developed as covalent inhibitors of thrombin.. These compounds demonstrated potent inhibitory activity, with derivatives 13a and 13b achieving IC50 values as low as 0.7 and 0.8 nM, respectively.. Mass-shift assays confirmed that these inhibitors covalently bind to the catalytic Ser195 of thrombin, leading to temporary inhibition of its activity through specific acylation. Recombinant:Article Title: Pyrazinyl-Substituted Aminoazoles as Covalent Inhibitors of Thrombin: Synthesis, Structure, and Anticoagulant Properties. Article Snippet: This study presents a novel series of N-acylated 1,2,4-triazol-5-amines and 1H-pyrazol-5-amines, featuring a pyrazin-2-yl moiety, developed as covalent inhibitors of thrombin.. These compounds demonstrated potent inhibitory activity, with derivatives 13a and 13b achieving IC50 values as low as 0.7 and 0.8 nM, respectively.. Mass-shift assays confirmed that these inhibitors covalently bind to the catalytic Ser195 of thrombin, leading to temporary inhibition of its activity through specific acylation. |